Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblasts.
暂无分享,去创建一个
M. Baron | D. Abraham | C. Denton | Shangxin Liu | A. Leask | X. Shi-wen | K. Thompson | K. Khan | Hannah Murphy-Marshman | Shijie Xu
[1] Yunliang Chen,et al. Loss of protein kinase C&egr; results in impaired cutaneous wound closure and myofibroblast function , 2014, Journal of Cell Science.
[2] A. Leask. Getting Out of a Sticky Situation: Targeting the Myofibroblast in Scleroderma , 2012, The open rheumatology journal.
[3] M. Kapoor,et al. Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation. , 2012, Arthritis and rheumatism.
[4] S. Kudoh,et al. Efficacy of inhaled N‐acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis , 2012, Respirology.
[5] B. McKay,et al. Focal adhesion kinase inhibitors are potent anti‐angiogenic agents , 2011, Molecular oncology.
[6] A. Giovannetti,et al. Long-Term N-Acetylcysteine Therapy in Systemic Sclerosis Interstitial Lung Disease: A Retrospective Study , 2011, International journal of immunopathology and pharmacology.
[7] A. Leask,et al. Mechanical Tension Increases CCN2/CTGF Expression and Proliferation in Gingival Fibroblasts via a TGFβ-Dependent Mechanism , 2011, PloS one.
[8] D. Abraham,et al. Expression of integrin β1 by fibroblasts is required for tissue repair in vivo , 2010, Journal of Cell Science.
[9] D. Hamilton,et al. ALK5 Inhibition Blocks TGFβ-induced CCN2 Expression in Gingival Fibroblasts , 2010, Journal of dental research.
[10] Robert Barrett,et al. Specific shRNA targeting of FAK influenced collagen metabolism in rat hepatic stellate cells. , 2010, World journal of gastroenterology.
[11] S. Rennard,et al. N-acetyl-L-cysteine inhibits TGF-beta1-induced profibrotic responses in fibroblasts. , 2009, Pulmonary pharmacology & therapeutics.
[12] B. Willis,et al. N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[13] A. Nicholson,et al. Lung function in idiopathic pulmonary fibrosis - extended analyses of the IFIGENIA trial , 2009, Respiratory research.
[14] M. Kapoor,et al. Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse model. , 2009, Arthritis and rheumatism.
[15] M. Kapoor,et al. Rac1 expression by fibroblasts is required for tissue repair in vivo. , 2009, The American journal of pathology.
[16] B. Hinz,et al. Tissue stiffness, latent TGF-β1 Activation, and mechanical signal transduction: Implications for the pathogenesis and treatment of fibrosis , 2009, Current rheumatology reports.
[17] Yunliang Chen,et al. Loss of protein kinase Cϵ results in impaired cutaneous wound closure and myofibroblast function , 2008, Journal of Cell Science.
[18] A. Leask. Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. , 2008, Cellular signalling.
[19] D. Abraham,et al. Fibroblast adhesion results in the induction of a matrix remodeling gene expression program. , 2008, Matrix biology : journal of the International Society for Matrix Biology.
[20] Yunliang Chen,et al. Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts. , 2007, Matrix biology : journal of the International Society for Matrix Biology.
[21] Yunliang Chen,et al. FAK is required for TGFbeta-induced JNK phosphorylation in fibroblasts: implications for acquisition of a matrix-remodeling phenotype. , 2007, Molecular biology of the cell.
[22] Christopher Autry,et al. Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor* , 2007, Journal of Biological Chemistry.
[23] Yunliang Chen,et al. CCN2 is necessary for the function of mouse embryonic fibroblasts. , 2007, Experimental cell research.
[24] B. van de Water,et al. Focal adhesion kinase: a potential target in cancer therapy. , 2007, Biochemical pharmacology.
[25] David Abraham,et al. Systemic sclerosis: a prototypic multisystem fibrotic disorder. , 2007, The Journal of clinical investigation.
[26] F Verrecchia,et al. [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.
[27] M. Aitio. N-acetylcysteine -- passe-partout or much ado about nothing? , 2006, British journal of clinical pharmacology.
[28] Yunliang Chen,et al. Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease. , 2005, The American journal of pathology.
[29] K. Csiszȧr,et al. Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis , 2005, Arthritis research & therapy.
[30] M. Jinnin,et al. Constitutive phosphorylation of focal adhesion kinase is involved in the myofibroblast differentiation of scleroderma fibroblasts. , 2005, The Journal of investigative dermatology.
[31] Yunliang Chen,et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. , 2004, Molecular biology of the cell.
[32] Andrew Leask,et al. TGF‐β signaling and the fibrotic response , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] Giulio Gabbiani,et al. Mechanisms of force generation and transmission by myofibroblasts. , 2003, Current opinion in biotechnology.
[34] J. Parsons,et al. Focal adhesion kinase: the first ten years , 2003, Journal of Cell Science.
[35] R. Day,et al. Myofibroblast Differentiation by Transforming Growth Factor-β1 Is Dependent on Cell Adhesion and Integrin Signaling via Focal Adhesion Kinase* , 2003, Journal of Biological Chemistry.
[36] E. Giannoni,et al. Reactive oxygen species as essential mediators of cell adhesion , 2003, The Journal of cell biology.
[37] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[38] F. Hirche,et al. Fibroblasts in Mechanically Stressed Collagen Lattices Assume a “Synthetic” Phenotype* , 2001, The Journal of Biological Chemistry.
[39] G. Gabbiani,et al. Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. , 2001, Journal of cell science.
[40] S. Sa,et al. CTGF and SMADs, Maintenance of Scleroderma Phenotype Is Independent of SMAD Signaling* , 2001, The Journal of Biological Chemistry.
[41] S. Sa,et al. Tumor Necrosis Factor α Suppresses the Induction of Connective Tissue Growth Factor by Transforming Growth Factor-β in Normal and Scleroderma Fibroblasts* , 2000, The Journal of Biological Chemistry.
[42] R. D. du Bois,et al. Scleroderma lung fibroblasts exhibit elevated and dysregulated type I collagen biosynthesis. , 1997, Arthritis and rheumatism.
[43] T. Krieg,et al. Differential regulation of transcription and transcript stability of pro-α 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma , 1996 .
[44] T. Medsger,et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.